{"pageContent": "Objective: To explore the association between the prostate-specific antigen (PSA) nadir after transrectal high-intensity focused ultrasound (HIFU) therapy for organ-confined prostate cancer and subsequent treatment failure, as defined by the presence of residual disease at biopsy 6 months after treatment.", "metaData": {"source": "The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel\nhttps://pubmed.ncbi.nlm.nih.gov/24215670/"}}